Cargando…

Indolent stage IVA thymic malignancies managed with multimodality treatments

Detalles Bibliográficos
Autor principal:	Hamaji, Masatsugu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794311/ https://www.ncbi.nlm.nih.gov/pubmed/35118284 http://dx.doi.org/10.21037/med.2020.03.03

Ejemplares similares

Treatment options for stage IVA thymic malignancies
por: Girard, Nicolas
Publicado: (2019)

Surgical Approaches for Stage IVA Thymic Epithelial Tumors
por: Shapiro, Mark, et al.
Publicado: (2014)

On the staging of thymic epithelial neoplasms
por: Suster, David, et al.
Publicado: (2019)

WT1 peptide-based immunotherapy for refractory thymic epithelial malignancies
por: Suzuki, Mikito, et al.
Publicado: (2019)

Salvage surgery for stage IVa thymic carcinoma combined with aortic arch resection – case report
por: Yamato, Hiroyuki, et al.
Publicado: (2020)

Best practices and guidelines for the management of thymic epithelial tumors
por: Giaccone, Giuseppe, et al.
Publicado: (2019)

Multiple mutations in the EGFR gene in lung cancer is rare but should not be forgettable
por: Miyata, Ryo, et al.
Publicado: (2022)

Successful multimodal treatment of stage IV lymphoepithelioma-like thymic carcinoma
por: Zielińska, Dominika, et al.
Publicado: (2022)

Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management
por: Sawamoto, Kazuki, et al.
Publicado: (2020)

Diagnostic and planned salvage pulmonary metastasectomy
por: Hamaji, Masatsugu, et al.
Publicado: (2022)

Multimodality approach in treatment of thymic tumors
por: Turna, Akif, et al.
Publicado: (2020)

The impact of radiomics in predicting oncologic behavior of thymic epithelial tumors
por: Ozawa, Yoshiyuki, et al.
Publicado: (2019)

Clinical TNM staging of thymic epithelial malignancies
por: Ackman, Jeanne B.
Publicado: (2019)

Bridging over troubled waters: the doubling time and histological subtypes of thymic epithelial tumors
por: Kashima, Jumpei, et al.
Publicado: (2020)

Induction chemotherapy for locally advanced thymic epithelial tumors: consideration from the RYTHMIC prospective cohort
por: Nakagawa, Kazuo
Publicado: (2019)

An overview: ongoing systemic therapy trials in thymic epithelial tumors around the world-will anything “hit”?
por: Merveilleux du Vignaux, Claire, et al.
Publicado: (2021)

Advancement in Diagnostic Imaging of Thymic Tumors
por: Gentili, Francesco, et al.
Publicado: (2021)

Radiotherapy for stage IVa thymoma—Shanghai Chest experience
por: Wang, Changlu, et al.
Publicado: (2019)

Multimodal Therapy of Upper Gastrointestinal Malignancies
por: Ronellenfitsch, Ulrich, et al.
Publicado: (2021)

Improvement of Malignant Pleural Mesothelioma Prognosis: Early Diagnosis and Multimodality Treatment
por: Ban, Cheng-Jun, et al.
Publicado: (2017)

Thymic cancer: A not-so-indolent cause of pericardial effusion
por: Whiting, Adrian, et al.
Publicado: (2021)

End-of-Life Care for Patients Afflicted with Incurable Malignancy and End-Stage Renal Disease
por: Bhowmik, Dipankar, et al.
Publicado: (2014)

Optimal management of thymic malignancies: current perspectives
por: Drevet, Gabrielle, et al.
Publicado: (2019)

WT1 as an immunotherapy target for thymic epithelial tumors: a novel method to activate anti-tumor immunity
por: Takahashi, Nobuyuki, et al.
Publicado: (2019)

A strike against indolent neuroblastoma
por: Cook, April, et al.
Publicado: (2020)

Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies
por: Mendogni, Paolo, et al.
Publicado: (2022)

Contrasting models of promiscuous gene expression by thymic epithelium
por: Gillard, Geoffrey O., et al.
Publicado: (2005)

Medullary Thymic Epithelium: A Mosaic of Epithelial “Self”?
por: Farr, Andrew G., et al.
Publicado: (1998)

Thymic stromal lymphopoietin: master switch for allergic inflammation
por: Liu, Yong-Jun
Publicado: (2006)

20/20 in 2020: seeking clarity on the management of stage III melanoma in a rapidly changing treatment environment
por: Chandrasekaran, Sanjay, et al.
Publicado: (2020)

Clinical Outcomes of Thymic Carcinoma: The Role of Radiotherapy Combined with Multimodal Treatments
por: Yang, Gowoon, et al.
Publicado: (2023)

Diagnosing mucopolysaccharidosis IVA
por: Wood, Timothy C., et al.
Publicado: (2013)

Thymic epithelial tumors diagnosis and management: the importance of an international multidisciplinary approach
por: Molina, Thierry Jo
Publicado: (2019)

Survival comparison between thymic carcinoma and thymic carcinoid: does it matter in clinical practice?
por: Hishida, Tomoyuki
Publicado: (2019)

Thymic Acid
Publicado: (1869)

Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir(®) therapy: A case report
por: Pumpure, Elizabete, et al.
Publicado: (2020)

“Self-Healing”: A Novel and Integrated Multimodal Concept for the Management of Musculoskeletal Pain
por: Mobasheri, Ali
Publicado: (2022)

The benefit of the doubt: PD-L1 status in unresectable stage III NSCLC management
por: Denault, Marie-Helene, et al.
Publicado: (2023)

Evaluation of the new TNM-staging system for thymic malignancies: impact on indication and survival
por: Ried, Michael, et al.
Publicado: (2017)

IVA 2000 : análisis práctico : (comentarios y casos) /
por: Corona Funes, José
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_07erln7msdo3hp8c7dn0dnkkdq